INDP
Indaptus Therapeutics Inc
2.40$
+12.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -16.1% | -26.6% | -25.8% | +1.5% | -10.9% | -26.3% | +26.4% | +0.0% | +36.1% | -76.6% | +449.7% | |
| – | -16.9% | -26.5% | -27.2% | +1.9% | -13.3% | -25.0% | +29.3% | +0.4% | +44.6% | -76.6% | +449.7% | |
| – | -16.3% | -27.1% | -25.0% | +1.1% | -21.6% | -32.8% | +58.3% | -5.4% | +46.0% | -82.4% | +404.4% | |
| – | -16.3% | -27.1% | -25.0% | +1.1% | -21.6% | -32.8% | +58.3% | -5.4% | +46.0% | -82.4% | +671.5% | |
| – | +15.7% | -44.2% | +23.2% | +14.4% | +51.8% | -23.0% | +225.9% | -73.8% | +175.6% | -84.9% | -34.0% | |
| – | +17.3% | -44.6% | +25.4% | +15.8% | +52.0% | -23.0% | +225.9% | -73.8% | +175.6% | -84.9% | -34.0% | |
| – | +0.7% | +0.7% | +0.7% | +0.7% | -19.1% | -29.3% | +10,884.1% | -99.9% | – | – | – | |
| – | +30.6% | -49.7% | +2.7% | +33.5% | +56.5% | +50.7% | -52.8% | +14.4% | -23.1% | +2.4% | +10.4% | |
| – | -21.2% | -22.5% | -34.1% | -2.6% | -34.3% | -29.0% | -159.8% | – | -31.6% | -60.4% | +811.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.5% | +1.2% | +11.3% | +16.6% | +27.2% | +14.1% | +73.4% | +117.4% | +405.5% | +959.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.